Agneta Scheja (Former)
1 – 20 of 54
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Raynaud’s phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
CD81 and CD48 show different expression on blood eosinophils in systemic sclerosis: new markers for disease and pulmonary inflammation?
(
- Contribution to journal › Article
- 2014
-
Mark
Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjogren's syndrome and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometry.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
(
- Contribution to journal › Article
-
Mark
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
(
- Contribution to journal › Article
-
Mark
Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database
(
- Contribution to journal › Article
- 2012
-
Mark
Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods
(
- Contribution to journal › Article
-
Mark
A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment.
(
- Contribution to journal › Article
-
Mark
Managing work life with systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
(
- Contribution to journal › Article
-
Mark
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
(
- Contribution to journal › Article
-
Mark
Comment on: A multicentre study on the reliability of qualitative and quantitative nailfold videocapillaroscopy assessment: reply.
(
- Contribution to journal › Article
- 2011
-
Mark
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult
(
- Contribution to journal › Article
-
Mark
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease
(
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
The Swedish version of the Multidimensional Assessment of Fatigue (MAF) in systemic sclerosis: reproducibility and correlations to other fatigue instruments.
(
- Contribution to journal › Article
-
Mark
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations.
(
- Contribution to journal › Article
- 2010
-
Mark
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
(
- Contribution to journal › Article
-
Mark
Expression of activation markers on eosinophils in patients with systemic sclerosis
(
- Contribution to journal › Published meeting abstract